Form 8-K - Current report:
SEC Accession No. 0001493152-25-004412
Filing Date
2025-01-31
Accepted
2025-01-31 16:05:15
Documents
13
Period of Report
2025-01-31
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43997
  Complete submission text file 0001493152-25-004412.txt   217260

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mrzm-20250131.xsd EX-101.SCH 3015
3 XBRL LABEL FILE mrzm-20250131_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE mrzm-20250131_pre.xml EX-101.PRE 24165
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3454
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME, INC. (Filer) CIK: 0001413754 (see all company filings)

EIN.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53223 | Film No.: 25578367
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)